title: The cholesterol and statin controversy: the new 2013 statin-cholesterol guidelines.
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Sinatra
authors.forename: Beverly B
authors.initials: BB
authors.lastname: Teter
authors.forename: Jonny
authors.initials: J
authors.lastname: Bowden
authors.forename: Mark C
authors.initials: MC
authors.lastname: Houston
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Martinez-Gonzalez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002309:Cardiology / Q000592:standards; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced; D058226:Plaque, Atherosclerotic / Q000188:drug therapy* / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D014481:United States
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors